Herpes zoster ophthalmicus
ICD-10 B02.3 · ICD-11 1E91.1

What Is the Treatment of Herpes Zoster Ophthalmicus?

Herpes zoster ophthalmicus requires prompt clinical management. Timely intervention — particularly regarding the initiation of antiviral therapy — is central to the standard treatment approach.

The foundation of management is antiviral therapy, with timing of initiation relative to rash onset being clinically significant. For herpes zoster ophthalmicus specifically, adjuvant measures are incorporated alongside antivirals to address pain and, in certain presentations, to support the eye. The complete agent selection, sequencing, and adjuvant strategy are detailed in the full protocol below.
Instant Access to Structured Evidence-Based Regimens

References

The standard treatment for HZ is antiviral medication, preferably initiated within 72 hours of rash onset.

For HZO in particular, adjuvant therapy is used. Analgesics or steroids are given to reduce pain. If blinking is impaired, lubricating and antibiotic ophthalmic ointments may be used.

View source ↗